drugset / Trial / NCT00906126

Oral Misoprostol for Labor Augmentation: A Pilot Study

NCT00906126

Phase 1 Completed 46 enrolled University of Texas Southwestern Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A phase I, open-label trial to determine a safe dose of oral misoprostol required to augment labor in nulliparous women diagnosed with arrest of dilation.

Timeline

Start
2007-04
Primary completion
2008-09
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 25 ug Oral
Subject Misoprostol Other / unclassified 50 ug Oral
Subject Misoprostol Other / unclassified 75 ug Oral
Subject Misoprostol Other / unclassified 100 ug Oral

Indications